Vaccination of the immunocompromised host

Key facts

Chair(s): Olivier Epaulard, Grenoble, France 

Approval date: March 2023 

Expected completion: May 2025 

Last status report date: 24.06.2024

Status Report

Guideline Development Steps

Status

Guideline Group Membership

Completed

Establishing Guideline Group Processes

Completed

Identifying Target Audience and Topic Selection

Completed

Consumer and Stakeholder Involvement

Completed

Conflict of Interest Considerations

Completed

(PICO) Question Generation

Completed

Considering Importance of Outcomes and Interventions, Values, Preferences and Utilities

Completed

Literature Searches

Completed

Screening of Literature

Completed

Data Extraction

Ongoing

Risk of Bias Assessment

Not started

Summarising Evidence

Not started

Judging Quality, Strength or Certainty of a Body of Evidence (GRADE)

Not started

Developing Recommendations and Determining their Strength (EtDs)

Not started

Wording of Recommendations and Considerations of Implementation, Feasibility and Equity

Not started

Reporting and Peer Review

Not started

Public Consultation Phase

Not started

Submission to the Journal

Not started

Publication

Not started

Dissemination and Implementation

Not started

Updating

Not started